Balyasny Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-148,559
| Closed | -$526K | – | 1965 |
|
|
2025
Q1 | $526K | Buy |
148,559
+98,311
| +196% | +$348K | ﹤0.01% | 1554 |
|
|
2024
Q4 | $190K | Sell |
50,248
-655
| -1% | -$2.48K | ﹤0.01% | 1748 |
|
|
2024
Q3 | $165K | Buy |
50,903
+28,016
| +122% | +$90.8K | ﹤0.01% | 1821 |
|
|
2024
Q2 | $43.5K | Buy |
+22,887
| New | +$43.5K | ﹤0.01% | 1805 |
|
|
2024
Q1 | – | Sell |
-19,698
| Closed | -$290K | – | 1954 |
|
|
2023
Q4 | $290K | Sell |
19,698
-677,183
| -97% | -$9.97M | ﹤0.01% | 1623 |
|
|
2023
Q3 | $12.8M | Sell |
696,881
-476,972
| -41% | -$8.73M | 0.03% | 556 |
|
|
2023
Q2 | $25.3M | Buy |
1,173,853
+753,012
| +179% | +$16.2M | 0.06% | 374 |
|
|
2023
Q1 | $12.3M | Sell |
420,841
-224,712
| -35% | -$6.59M | 0.03% | 552 |
|
|
2022
Q4 | $23.9M | Buy |
645,553
+454,219
| +237% | +$16.8M | 0.07% | 335 |
|
|
2022
Q3 | $5.39M | Buy |
+191,334
| New | +$5.39M | 0.02% | 727 |
|
|
2022
Q2 | – | Sell |
-62,915
| Closed | -$808K | – | 2265 |
|
|
2022
Q1 | $808K | Buy |
+62,915
| New | +$808K | ﹤0.01% | 1372 |
|